Baylor College of Medicine – BOTSWANA

The Baylor (College of Medicine) International Pediatric AIDS Initiative (BIPAI), working in partnership with the government of Botswana, opened the Botswana-Baylor Children’s Clinical Center of Excellence in 2003. The facility, the first of its kind on the African continent, provides and supervises state-of-the-art care and treatment for more than 4,000 HIV-infected children and families throughout Botswana, both at the center and through its clinical mentoring program.

Staffed by Botswana and U.S. health care professionals, the center provides primary and specialty medical care and social services for HIV-infected infants, children, and their families. BIPAI Botswana maintains an annual mortality rate of <1%, a rate as good as any Western nation, and the majority of its patients are thriving.

Education and clinical research are integral to the center’s mission. Collaborative activities include development of curricula on pediatric health and HIV/AIDS for health care professionals, U.S.-Africa exchange fellowships, and training for African health care professionals at Baylor College of Medicine. Learn more about BIPAI Botswana’s education and training programs.

Dr. Gabriel Anabwani, professor of clinical pediatrics at Baylor College of Medicine, directs the Botswana-Baylor Children’s Clinical Center of Excellence. Dr. Anabwani is the former chair of pediatrics at Princess Marina Hospital in Gaborone, Botswana’s largest hospital. He has extensive leadership experience in pediatric HIV/AIDS care and treatment and clinical research in Africa. Learn more about BIPAI Botswana’s research.

The Botswana-Baylor Children’s Clinical Center of Excellence is the product of a partnership between BIPAI, Princess Marina Hospital , and the government of Botswana. It was made possible by a $6 million grant from the Bristol-Myers Squibb Foundation’s Secure the Future program. The center is also supported by the Fogarty International Center of the U.S. National Institutes of Health and the U.S. Centers for Disease Control and Prevention’s Global AIDS Program.

Comments are closed